p73 overexpression and angiogenesis in human colorectal carcinoma

Japanese Journal of Clinical Oncology

Volumn 33, Issue 5, 2003, Pages 215-220

  Guan, Ming ^a   Peng, Hai Xia ^b   Yu, Bo ^c   Lu, Yuan ^a  

^a FUDAN UNIVERSITY   (China)

^b Central Hospital of Changning   (China)

^c Nanshan Hospital   (China)

Author keywords

Angiogenesis; Colorectal cancer; p73; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; MONOCLONAL ANTIBODY; PROTEIN P53; PROTEIN P73; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VON WILLEBRAND FACTOR; DNA BINDING PROTEIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; P73 GENE; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; WESTERN BLOTTING; ADENOCARCINOMA; BIOSYNTHESIS; COLORECTAL TUMOR; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINAL MUCOSA; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0043201364     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg045     Document Type: Article

References (36)

1. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-51.
2. Stearns MW Jr. Staging colonic and rectal cancer. Int Adv Surg Oncol 1981;4:189-208.
3. Fisher PB. In: Slaga TJ, editor. Tumor Promotion and Carcinogenesis In vitro: Mechanisms of Tumor Promotion. Boca Raton, FL: CRC Press 1984;57-123.
4. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50:6130-8.
5. Su ZZ, Shi Y, Fisher PB. Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene. Proc Natl Acad Sci USA 1997;94:9125-30.
6. Kang DC, LaFrance R, Su ZZ, Fisher PB. Reciprocal subtraction differential RNA display: An efficient and rapid procedure for isolating differentially expressed gene sequences. Proc Natl Acad Sci USA 1998;95:13788-93.
7. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582-4.
8. Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, et al. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis and tumor progression. J Natl Cancer Inst 1997;89:219-27.
9. Holmgren L, Jackson G, Arbiser J. p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma. Oncogene 1998;17:819-24.
10. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-19.
11. Jost CA, Marin MC, Kaelin WG Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997;389:191-4.
12. Stiewe T, Putzer BM. p73 in apoptosis. Apoptosis 2001;6:447-52.
13. Zaika AI, Kovalev S, Marchenko ND, Moll UM. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 1999;59:3257-63.
14. Yokomizo A, Mai M, Tindall DJ, Cheng L, Bostwick DG, Naito S, et al. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 1999;18:1629-33.
15. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 1999;91:1154-8.
16. Novak U, Grob TJ, Baskaynak G, Peters UR, Aebi S, Zwahlen D, et al. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Ann Oncol 2001;12:981-6.
17. Sun XF. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res 2002;8:165-70.
18. Liu L, Cui X, Sakaguchi T, Sasaki M, Suda T, Hatakeyama K. Expression of p73 in colorectal carcinoma: Clinicopathological relevance. J Int Med Res 2001;29:297-303.
19. Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K, Tokino T. Adeno-virus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Gene Ther 2001;8:1401-8.
20. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
21. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Adv Cancer Res 1996;69:135-74.
22. Rak J, Klement G. Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer. Cancer Metastasis Rev 2000;19:93-6.
23. Kovalev S, Marchenko N, Swendeman S, LaQuaglia M, Moll UM. Expression level, allelic origin and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ 1998;9:897-903.
24. Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI, et al. Activation of p73 silent allele in lung cancer. Cancer Res 1998;58:2347-9.
25. Tokuchi Y, Hashimoto T, Kobayashi Y, Hayashi M, Nishida K, Hayashi S, et al. The expression of p73 is increased in lung cancer, independent of p53 gene alteration. Br J Cancer 1999;80:1623-9.
26. Cai YC, Yang GY, Nie Y, Wang LD, Zhao X, Song YL, et al. Molecular alterations of p73 in human esophageal squamous cell carcinomas: Loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression maybe related to defective p53. Carcinogenesis 2000;21:683-9.
27. Kang MJ, Park BJ, Byun DS, Park JI, Kim HJ, Park JH, et al. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res 2000;6:1767-71.
28. Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, et al. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol 1998;13:319-23.
29. Chi SG, Chang SG, Lee SJ, Lee CH, Kim JI, Park JH. Elevated and biallelic expression of p73 is associated with progression of human bladder cancer. Cancer Res 1999;59:2791-3.
30. Ng SW, Yiu GK, Liu Y, Huang LW, Palnati M, Jun SH, et al. Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene 2000;19: 1885-90.
31. Chen CL, Ip SM, Cheng D, Wong LC, Ngan HY. p73 gene expression in ovarian cancer tissues and cell lines. Clin Cancer Res 2000;6:3910-5.
32. Zwahlen D, Tschan MP, Grob TJ, Peters UR, Fink D, Haenggi W, et al. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours. Int J Cancer 2000;88:66-70.
33. Loiseau H, Arsaut J, Demotes-Mainard J. p73 gene transcripts in human brain tumors: Overexpression and altered splicing in ependymomas. Neurosci Lett 1999;263:173-6.
34. Herath NI, Kew MC, Whitehall VL, Walsh MD, Jass JR, Khanna KK, et al. p73 is up-regulated in a subset of hepatocellular carcinomas. Hepatology 2000;31:601-5.
35. Stiewe T, Zimmermann S, Frilling A, Esche H, Putzer BM. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res 2002;62: 3598-602.
36. Vikhanskaya F, Bani MR, Borsotti P, Ghilardi C, Ceruti R, Ghisleni G, et al. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: Implications for tumor angiogenesis. Oncogene 2001;20: 7293-300.